G12.2
Motor neuron disease
Clinical Classification Guidelines
Medical Intelligence & Overview
Motor neuron disease (MND) refers to a group of neurological disorders that progressively damage the neurons responsible for controlling voluntary muscle activity. These neurons include motor neurons in the brain and spinal cord that communicate signals to muscles, enabling movement, speech, swallowing, and breathing. As these cells deteriorate, individuals may experience muscle weakness, loss of dexterity, and difficulties with daily activities. The most common form of MND is Amyotrophic Lateral Sclerosis (ALS), but there are other types with varying patterns of progression.
Causes & Symptoms
Clinical Causes: Genetic mutations: Some cases are inherited due to specific gene mutations. Environmental factors: Potential exposure to toxins, chemicals, or heavy metals may increase risk. Age-related factors: Incidence increases with age, particularly in adults over 50. Unknown origins: In many instances, the exact cause remains unidentified.
Key Symptoms: Muscle weakness: Frequently starting in one limb or part of the body. Muscle twitching (fasciculations): Small involuntary contractions visible under the skin. Muscle cramps and stiffness: Resulting from nerve degeneration. Difficulty speaking: Slurred speech or trouble articulating words. Swallowing difficulties: Choking or nasal regurgitation when eating or drinking. Breathing problems: Shortness of breath or reduced respiratory capacity as muscles weaken. Loss of muscle mass: Progressive wasting of affected muscles. Balance and coordination issues: Falling or unsteady gait in later stages.
Diagnostic & Treatment
Diagnosis Path: Electromyography (EMG): Tests electrical activity in muscles to detect nerve damage. Nerve conduction studies: Measure how well nerves transmit signals. MRI scans: Image of the brain and spinal cord to exclude other causes. Blood and urine tests: Check for other conditions or underlying factors. Lumbar puncture: Cerebrospinal fluid analysis to identify infections or inflammation.
Treatment Protocols: Medications: Riluzole and edaravone may slow disease progression. Physical therapy: Exercises to maintain muscle strength and prevent contractures. Speech therapy: Assistance with communication and swallowing difficulties. Nutritional support: Dietary adjustments or feeding tubes in advanced stages. Respiratory care: Use of ventilators or breathing support as muscles weaken. Assistive devices: Mobility aids, communication devices, and adaptive tools.
Clinical Advice & FAQs
Billing Guidance
Is G12.2 a billable ICD-10 code?
Yes, G12.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G12.2?
Clinical documentation must specify the nature of Motor neuron disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference